The pharmacokinetics of intravenous estradiol - A preliminary study

Pharmacotherapy

Volumn 18, Issue 6 I, 1998, Pages 1343-1346

  White, C Michael ^a   Ferraro Borgida, Melissa J ^b   Fossati, Andrea T ^b   McGill, Carol C ^b   Ahlberg, Alan W ^b   Feng, Yue Jin ^b   Heller, Gary V ^a,b   Chow, Moses S S ^a,b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GEMFIBROZIL; PRAVASTATIN; THIAZIDE DIURETIC AGENT;

AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG TOLERABILITY; FEMALE; HORMONE SUBSTITUTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; POSTMENOPAUSE;

AGED; AREA UNDER CURVE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MIDDLE AGED;

EID: 0031726612     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. +, and U-46619. J Cardiovasc Pharmacol 1995;25:200-6.
2. Keaney JF, Shawaery GT, Wu A, et al. 17B-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation 1994;89:2251-9.
3. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 1992;20:452-7.
4. Lieberman EH, Gerhard MD, Uehata A, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994;121:936-41.
5. Rosano GM, Peters NS, Lefroy D, et al. 17-beta-estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol 1996;28:1500-5.
6. Ginsburg ES, Walsh BW, Shea BF, Gao X, Gleason RE, Barbieri RL. The effects of ethanol on the clearance of estradiol in post-menopausal women. Fertil Steril 1995;63:1227-30.
7. Challis JR, Davies IJ, Ryan KJ. The concentration of progesterone, estrone, and estradiol 17beta in the plasma of pregnant rabbits. Endocrinology 1973;93:971-6.
8. 3H-estrone. J Clin Endocrinol Metab 1974;38:602-7.
9. Purdy RH, Engel LL, Oncley JL. The characterization of estrone sulfate from human plasma. J Biol Chem 1961;236: 1043-50.
10. Magness RR, Rosenfeld CR. Local and systemic estradiol-17 B: effects on uterine and systemic vasodilation. Am J Physiol 1989;256:E536-42.
11. Rosano GM, Sarrel PM, Poole-Wilson P, Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 1993;342: 133-6.
12. Anonymous. Physicians GenRx text. St Louis, MO: Mosby, 1996.
13. Place VA, Powers M, Darley PE, Schenkel L, Good WR. A double-blind comparative study of estraderm, and premarin in the amelioration of postmenopausal symptoms. Am J Obstet Gynecol 1985;152:1092-9.
14. Mashchak CA, Lobo RA, Dozono-Takano R, et al. Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol 1982;144:511.
15. Powers MS, Schenkel L, Darley PE, Good WR, Balestra JC, Place VA. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17-beta estradiol: comparison with conventional oral estrogens used for hormone replacement. Am J Obstet Gynecol 1985;152:1099-1106.
16. Simon TL, Hyers TM, Gaston JP. Heparin pharmacokinetics: increased requirements in pulmonary embolism. Br J Haematol 1978;39:111-20.
17. Longscope C, Hui SL, Johnston CC. Free estradiol, free testosterone, and sex hormone-binding globulin in perimenopausal women. J Clin Endocrinol Metab 1987;64: 513-18.
18. Steinberg KK, Freni-Titulaer LW, Depuy EG, et al. Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab 1989;69:533-9.
19. Zeleniuch-Jacquotte A, Bruning PF, Bonfrer JM, et al. Relation of serum levels of testosterone and dehydroepiandosterone sulfate to risk of breast cancer in post-menopausal women. Am J Epidemiol 1997;145:1030-8.
20. Shultz TD. Physiological free fatty acid concentrations do not increase free estradiol in plasma. J Clin Endocrinol Metab 1991;72:65-8.
21. Cooke RR, McIntosh JE, Murray-McIntosh RP. Effect of cortisol on percentage of non-sex-hormone-bound steroid: implications for distribution of steroids on binding proteins in serum. Clin Chem 1996;42:249-54.
22. Cipolle RJ, Seifert RD, Neilan BA, Zaske DE, Haus E. Heparin kinetics: variables related to disposition and dosage. Clin Pharmacol Ther 1981;29:387-93.
23. Sven LZ, Oie S, Schwartz JB. Design and optimization of dosage regimens; pharmacokinetic data. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's the pharmacologic basis of therapeutics, 9th ed. New York: McGraw-Hill, 1996:1707-92.
24. Cipolle RJ, Rodvold KA. Heparin. In: Evans WE, Schentag JJ, Jusko WJ, eds. Applied pharmacokinetics: principles of therapeutic drug monitoring. Vancouver, WA: Applied Therapeutics, 1986:30.1-39.
25. Shargel L, Yu ABC. Applied biopharmaceutics and pharmacokinetics, 3rd ed. Norwalk, CT: Appleton & Lange, 1993.
26. U.S. Pharmacopeia. Drug information for the health care professional, 15th ed., USPDI. Rockville, MD: U.S. Pharmacopeia, 1995.
27. Craft PP, Foil MB, Cunningham PR, Patselas PC, Long-Snyder BM, Collier MS. Intravenous ethanol for alcohol detoxification in trauma patients. South Med J 1994;87:47-54.